Surveys from 2020 showed that about 1 in 4 adults with recent chronic pain reported using pharmacologic therapies only, showing a need to increase nonpharmacologic therapy use, according to the study authors.
An industry-funded trial found that ubrogepant was associated with absence of moderate or severe headache within 24 hours 46% of the time versus 29% with placebo when taken during the prodrome period (nonaura symptoms preceding headache onset).
Researchers suggest ways for clinicians to assess cognitive function, manual dexterity/strength, and peak inspiratory flow before choosing an inhaled medication delivery system for patients with chronic obstructive pulmonary disease (COPD).
Register now for ACP's and Annals of Internal Medicine's forum on controversies in colorectal cancer screening
A panel of experts will discuss colorectal cancer screening options based on diagnostic test accuracy, effectiveness, and potential harm during the virtual live event on Dec. 6 from 3:30 to 5 p.m. ET.
The app provides on-the-go access to the latest College news, information, tools, and resources, as well as opportunities to communicate with colleagues.